Federated Hermes
DFTX

Federated Hermes’s Definium Therapeutics DFTX Stock Holding History

Federated Hermes’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-207
Closed -$3.91K – 2130
2026
Q1 		$3.91K Buy
207
+140
+209% +$2.38K ﹤0.01% 1915
2025
Q4 		$897 Buy
+67
New +$829 ﹤0.01% 2025
2024
Q2 		– Sell
-247
Closed -$2.32K – 2097
2024
Q1 		$2.32K Buy
+247
New +$1.41K ﹤0.01% 1906
2022
Q1 		– Sell
-405
Closed -$8K – 2269
2021
Q4 		$8K Sell
405
-5
-1% -$160 ﹤0.01% 1951
2021
Q3 		$14K Buy
+410
New +$17.7K ﹤0.01% 1961

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Federated Hermes's DFTX Position: Q2 2026 in Review

Federated Hermes sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 207 shares — an estimated $3.91K sold.

Federated Hermes first reported a position in DFTX in Q3 2021 and held it in 5 quarters. The position peaked at $14K in Q3 2021. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Federated Hermes reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 207 Definium Therapeutics shares in Q2 2026, an estimated $3.91K.
  • Federated Hermes first reported a position in Definium Therapeutics in Q3 2021 and held it in 5 quarters.
  • Federated Hermes's Definium Therapeutics position peaked at $14K in Q3 2021.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.